Thonzylamine
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
![]() |
|
Systematic (IUPAC) name | |
---|---|
N-(4-methoxybenzyl)-N',N'-dimethyl-N-pyrimidin-2-ylethane-1,2-diamine
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 91-85-0 ![]() |
ATC code | D04AA01 (WHO) R01AC06 R06AC06 |
PubChem | CID: 5457 |
ChemSpider | 5258 ![]() |
UNII | R79646H5Z8 ![]() |
KEGG | D08587 ![]() |
ChEMBL | CHEMBL1623738 ![]() |
Synonyms | Neohetramine |
Chemical data | |
Formula | C16H22N4O |
Molecular mass | 286.372 g/mol |
|
|
|
|
![]() ![]() |
Thonzylamine (or neohetramine)[1] is an antihistamine and anticholinergic used as an antipruritic.
Synthesis
![](/w/images/thumb/4/4d/Thonzylamine_synthesis.svg/700px-Thonzylamine_synthesis.svg.png)
Thonzylamine synthesis: H. L. Friedman and A, V. Tolstouhov, U.S. Patent 2,465,865 (1949).
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
Antihistamines for topical use | |
---|---|
Anesthetics for topical use | |
Others |
|
Decongestants and other nasal preparations (R01)
|
|||||||||
---|---|---|---|---|---|---|---|---|---|
Topical |
|
||||||||
Systemic use: Sympathomimetics |
Aminoalkyl ethers |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Substituted alkylamines | |||||||||
Substituted ethylenediamines |
|
||||||||
Phenothiazine derivatives | |||||||||
Piperazine derivatives | |||||||||
Others for systemic use |
|
||||||||
For topical use | |||||||||
|
Receptor (ligands) |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Transporter (inhibitors) |
|
||||||||
Enzyme (inhibitors) |
|
||||||||
Others |
|
||||||||
|
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |